iBio Reports Preliminary Unaudited Fiscal Year 2022
BRYAN, Texas and SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation...
Source: globenewswire.com
Fastpharming Contract Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Fastpharming Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Fastpharming Contract Development Today - Breaking & Trending Today
iBio Reports Fiscal Second Quarter 2022 Financial Results
BRYAN, Texas, Feb. 14, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...
Source: globenewswire.com
iBio to Report Fiscal 2022 Second Quarter Financial Results and Provide Corporate Update on Monday, February 14, 2022
07.02.2022 - BRYAN, Texas, Feb. 07, 2022 (GLOBE NEWSWIRE) - iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System, announced today that ...
Source: wallstreet-online.de
iBio Announces Partial Adjournment of Annual Meeting of
- Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin -...
Source: globenewswire.com
iBio Appoints William D. Clark to its Board of Directors
Industry veteran adds deep expertise in immuno-oncology to the Board...
Source: globenewswire.com